Mitsubishi UFJ Trust & Banking Corp acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 61,908 shares of the company's stock, valued at approximately $10,299,000.
Several other hedge funds also recently modified their holdings of the stock. Nordea Investment Management AB bought a new position in shares of Astera Labs during the fourth quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in shares of Astera Labs during the third quarter valued at approximately $1,876,000. Numerai GP LLC increased its stake in shares of Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company's stock valued at $2,587,000 after purchasing an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB increased its stake in shares of Astera Labs by 289.5% during the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company's stock valued at $24,710,000 after purchasing an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC bought a new position in shares of Astera Labs during the third quarter valued at approximately $1,829,000. Institutional investors own 60.47% of the company's stock.
Insider Activity at Astera Labs
In related news, CEO Jitendra Mohan sold 10,188 shares of the firm's stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $175.45, for a total value of $1,787,484.60. Following the sale, the chief executive officer owned 4,069,134 shares in the company, valued at approximately $713,929,560.30. This trade represents a 0.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of the firm's stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the completion of the sale, the director owned 67,144 shares in the company, valued at $11,758,257.28. This represents a 5.30% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,064,888 shares of company stock worth $150,764,723. Company insiders own 12.50% of the company's stock.
Astera Labs Stock Up 4.1%
Shares of ALAB opened at $202.68 on Friday. The company has a market capitalization of $34.72 billion, a P/E ratio of 166.13, a price-to-earnings-growth ratio of 3.83 and a beta of 1.78. The firm has a 50 day moving average of $139.00 and a 200 day moving average of $153.38. Astera Labs, Inc. has a twelve month low of $63.40 and a twelve month high of $262.90.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm's quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.48 EPS for the current year.
Analysts Set New Price Targets
ALAB has been the subject of a number of analyst reports. Stifel Nicolaus set a $236.00 target price on shares of Astera Labs in a research note on Friday. Loop Capital assumed coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a "buy" rating and a $250.00 price target for the company. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 price target on shares of Astera Labs in a research report on Tuesday, April 21st. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research report on Friday. They set a "neutral" rating and a $153.00 price target for the company. Finally, Citigroup assumed coverage on shares of Astera Labs in a research report on Thursday, April 2nd. They set a "buy" rating and a $200.00 price target for the company. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $199.20.
View Our Latest Report on ALAB
About Astera Labs
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.